Pathology of peritoneal metastases [electronic resource] : the unchartered fields / Olivier Glehen, Aditi Bhatt, editors.

Saved in:
Bibliographic Details
Online Access: Full Text (via Springer)
Other Authors: Glehen, Olivier, Bhatt, Aditi
Format: Electronic eBook
Language:English
Published: Singapore : Springer, 2020.
Subjects:

MARC

LEADER 00000cam a2200000xa 4500
001 b11000689
006 m o d
007 cr |||||||||||
008 200504s2020 si o 000 0 eng d
005 20240423172722.2
019 |a 1153777624 
020 |a 9789811537738  |q (electronic bk.) 
020 |a 9811537739  |q (electronic bk.) 
020 |z 9811537720 
020 |z 9789811537721 
035 |a (OCoLC)spr1153060150 
035 |a (OCoLC)1153060150  |z (OCoLC)1153777624 
037 |a spr978-981-15-3773-8 
040 |a YDX  |b eng  |c YDX  |d EBLCP  |d GW5XE 
049 |a GWRE 
050 4 |a RC280.P38 
245 0 0 |a Pathology of peritoneal metastases  |h [electronic resource] :  |b the unchartered fields /  |c Olivier Glehen, Aditi Bhatt, editors. 
260 |a Singapore :  |b Springer,  |c 2020. 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
505 0 |a Intro -- Preface -- Contents -- About the Editors -- 1: Mechanisms of Peritoneal Metastasis Formation -- 1.1 Introduction -- 1.2 Mechanisms of Trans-mesothelial Metastasis -- 1.2.1 Mechanisms of Cancer Cell Spillage into the Peritoneal Cavity -- 1.2.2 Adhesion of PFCCs and Mesothelial Cells (Fig. 1.1, Process 1) -- 1.2.3 Morphological Changes of Mesothelial Cells (Fig. 1.1, Process 1), Submesothelial Invasion of PFCCs, Attachment of PFCCs to the Basement Membrane (Fig. 1.1, Process 2) -- 1.2.4 Adhesion of PFCCS to the Submesothelial Basement Membrane (Fig. 1.1, Process 2 and Fig. 1.6) 
505 8 |a 1.2.5 Invasion into the Submesothelial Tissue (Fig. 1.1, Process 3) -- 1.2.6 Destruction of Submesothelial Basement Membrane and Extracellular Matrix (ECM) and Invasion into Submesothelial Tissue (Fig. 1.1, Process 3) -- 1.2.7 Proliferation in the Subperitoneal Tissue (Fig. 1.1, Process 4: Angiogenesis and Proliferation) -- 1.3 Trans-lymphatic Metastasis -- 1.4 Mechanisms of Superficial Growing Metastasis -- References -- 2: Extent of Peritoneal Resection for Peritoneal Metastases: Inferences from Pathophysiology -- 2.1 Background and Introduction. 
505 8 |a 2.1.1 Evolution of Peritoneal Surface Oncology -- 2.2 Pathophysiology of Peritoneal Metastases and Its Clinical Implications -- 2.2.1 Peritoneal Metastatic Cascade -- 2.2.2 Distribution of Disease in the Peritoneal Cavity -- 2.2.2.1 Epithelial Ovarian Cancer -- 2.2.3 Implications of Mechanism of Peritoneal Dissemination on Surgical Resection -- 2.2.4 Morphology of Peritoneal Deposits and Morphological Evolution of Peritoneal Metastases -- 2.2.4.1 Morphological Evolution of PM -- 2.2.4.2 Alteration in Morphology After Systemic Chemotherapy -- 2.2.4.3 Histological Subtype. 
505 8 |a 2.2.5 Impact on the Extent of Surgical Resection -- 2.2.6 Resection of Uninvolved Regions -- 2.2.7 Primary Tumor Type -- 2.2.8 Lymphadenectomy in Addition to Cytoreductive Surgery -- 2.2.9 Prognostic Implications of Lymph Node Involvement -- 2.3 Extent of Peritoneal Resection for PM Arising from Various Primary Tumors -- 2.3.1 Studies Looking at the Extent of Peritoneal Resection -- 2.3.2 Application in Clinical Practice and Question for Future Research -- 2.4 Conclusions -- References -- 3: Therapeutic Rationale and Data Set for Reporting Cytoreductive Surgery Specimens. 
505 8 |a 3.1 Introduction -- 3.2 Anatomical Considerations -- 3.2.1 Peritoneal Regions -- 3.2.2 Lymphatic Drainage -- 3.2.3 Subperitoneal Nodes -- 3.2.4 Omental Nodes -- 3.2.5 Retroperitoneal Nodes -- 3.2.6 Paracardiac and Mediastinal Nodes -- 3.3 Pathological Evaluation of Cytoreductive Surgery Specimens -- 3.3.1 The Surgeon's Role -- 3.3.1.1 Labelling of Surgical Specimens by the Surgeon -- 3.3.1.2 Morphological Description -- 3.3.2 The Pathologist's Role -- 3.3.2.1 Handling of Specimens by the Pathologist -- 3.3.2.2 Gross Description and Sectioning -- Peritonectomy Specimen(s) 
650 0 |a Peritoneum  |x Cancer.  |0 http://id.loc.gov/authorities/subjects/sh2010010038. 
700 1 |a Glehen, Olivier.  |0 http://id.loc.gov/authorities/names/n2014182439. 
700 1 |a Bhatt, Aditi.  |0 http://id.loc.gov/authorities/names/n2018187411. 
776 0 8 |c Original  |z 9811537720  |z 9789811537721  |w (OCoLC)1141147264. 
856 4 0 |u https://colorado.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-15-3773-8  |z Full Text (via Springer) 
907 |a .b110006896  |b 06-01-20  |c 05-11-20 
998 |a web  |b 05-31-20  |c b  |d b   |e -  |f eng  |g si   |h 0  |i 1 
907 |a .b110006896  |b 06-01-20  |c 05-11-20 
944 |a MARS 
915 |a I 
956 |a Springer e-books 
956 |b Springer Nature - Springer Medicine eBooks 2020 English International 
999 f f |i 43407037-c013-58d6-ba4e-ea72f7e50465  |s 41c52b31-cb1d-5452-8b42-a30606795103 
952 f f |p Can circulate  |a University of Colorado Boulder  |b Online  |c Online  |d Online  |e RC280.P38  |h Library of Congress classification  |i Ebooks, Prospector  |n 1